The dry eye products market size has grown strongly in recent years. It will grow from $8.12 billion in 2025 to $8.62 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increasing screen time exposure, rising aging population, growing awareness of dry eye syndrome, expanded availability of OTC eye care products, higher diagnosis rates of ocular surface disorders.
The dry eye products market size is expected to see strong growth in the next few years. It will grow to $11.13 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing demand for personalized eye care solutions, rising adoption of anti-inflammatory dry eye treatments, expansion of e-commerce pharmaceutical sales, growing focus on chronic eye condition management, increasing product innovation in ocular therapeutics. Major trends in the forecast period include growing demand for preservative-free artificial tears, increasing adoption of gel-based lubricants, rising focus on long-lasting dry eye formulations, expansion of combination therapy products, enhanced emphasis on symptom-specific treatments.
The extended use of electronic devices, leading to prolonged screen time, is also anticipated to contribute to the growth of the dry eye products market. Prolonged screen time involves prolonged use of electronic devices, and the application of dry eye products is common to alleviate discomfort and manage symptoms related to digital eye strain. For instance, in September 2024, according to PubMed Central, a US government research repository, a 2024 systematic review estimated the global prevalence of dry eye disease at 11.59%, while pooled estimates for the United States were about 8.1%, illustrating the measurable and growing burden across regions. Therefore, the phenomenon of prolonged screen time is a significant factor driving the dry eye products market.
Prominent companies in the dry eye products market are actively engaged in the development of prescription eye drops, such as perfluorohexyloctane ophthalmic solution, to address evaporative dry eye and gain a competitive edge. This specialized eye drop targets evaporative dry eye by reducing tear evaporation at the ocular surface. For example, in September 2023, Bausch + Lomb, a Canada-based eye health products company, introduced Miebo, a prescription eye drop designed to treat dry eye disease by directly addressing tear evaporation. Miebo, a perfluorohexyloctane ophthalmic solution, focuses on alleviating signs and symptoms of dry eye, particularly in cases of evaporative dry eye. Notably, Miebo is a single-ingredient eye drop that is free from water, preservatives, and steroids, providing quick and comfortable spread to reduce tear evaporation at the ocular surface.
In February 2025, Abdi İbrahim İlaç Sanayi ve Ticaret A.Ş., a Turkey-based pharmaceutical company, partnered with Rohto Pharmaceutical to launch innovative eye care products in Turkey. The collaboration aims to introduce advanced eye care technologies, including TearShield-based formulations, improve patient experience, and strengthen both companies’ presence in the ophthalmic market. Rohto Pharmaceutical Co., Ltd., based in Japan, specializes in pharmaceuticals, cosmetics, and other fast-moving consumer goods.
Major companies operating in the dry eye products market are Alcon Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., URSAPHARM Arzneimittel GmbH, AFT Pharmaceuticals Limited, Novaliq GmbH, Théa Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Lupin Limited, Pfizer Inc., Merck & Co. Inc., Bayer AG, Prestige Consumer Healthcare Inc., Similasan AG.
North America was the largest region in the dry eye products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dry eye products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dry eye products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the dry eye products market by increasing costs of imported pharmaceutical ingredients, packaging materials, applicators, and formulation equipment. Manufacturers and distributors in North America and Europe are most affected due to dependence on global supply chains, while Asia-Pacific faces pricing pressure on finished product exports. These tariffs are contributing to higher retail prices and margin pressures. However, they are also encouraging local formulation, regional manufacturing expansion, and diversification of ingredient sourcing strategies.
The dry eye products market research report is one of a series of new reports that provides dry eye products market statistics, including dry eye products industry global market size, regional shares, competitors with a dry eye products market share, detailed dry eye products market segments, market trends and opportunities, and any further data you may need to thrive in the dry eye products industry. This dry eye products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Dry eye products are designed to address and alleviate the symptoms of dry eye syndrome, a condition characterized by insufficient tear production or rapid evaporation of tears. These products work by lubricating the eyes, reducing inflammation, and increasing moisture to provide relief from dryness, irritation, and discomfort.
The primary categories of dry eye products include antibiotic drops, hormone drops, artificial tears, and other formulations. Antibiotic drops, specifically designed for ophthalmic (eye) use, incorporate antibiotics to eliminate infections and mitigate inflammation, ultimately easing the symptoms associated with dry eye disease. These products encompass both prescription and over-the-counter drugs, available through various distribution channels such as hospital pharmacies, retail pharmacies, specialty clinics, e-commerce, and other outlets.
The dry eye products market consists of sales of cyclosporine, corticosteroids, and lifitegrast. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The dry eye products market size is expected to see strong growth in the next few years. It will grow to $11.13 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing demand for personalized eye care solutions, rising adoption of anti-inflammatory dry eye treatments, expansion of e-commerce pharmaceutical sales, growing focus on chronic eye condition management, increasing product innovation in ocular therapeutics. Major trends in the forecast period include growing demand for preservative-free artificial tears, increasing adoption of gel-based lubricants, rising focus on long-lasting dry eye formulations, expansion of combination therapy products, enhanced emphasis on symptom-specific treatments.
The extended use of electronic devices, leading to prolonged screen time, is also anticipated to contribute to the growth of the dry eye products market. Prolonged screen time involves prolonged use of electronic devices, and the application of dry eye products is common to alleviate discomfort and manage symptoms related to digital eye strain. For instance, in September 2024, according to PubMed Central, a US government research repository, a 2024 systematic review estimated the global prevalence of dry eye disease at 11.59%, while pooled estimates for the United States were about 8.1%, illustrating the measurable and growing burden across regions. Therefore, the phenomenon of prolonged screen time is a significant factor driving the dry eye products market.
Prominent companies in the dry eye products market are actively engaged in the development of prescription eye drops, such as perfluorohexyloctane ophthalmic solution, to address evaporative dry eye and gain a competitive edge. This specialized eye drop targets evaporative dry eye by reducing tear evaporation at the ocular surface. For example, in September 2023, Bausch + Lomb, a Canada-based eye health products company, introduced Miebo, a prescription eye drop designed to treat dry eye disease by directly addressing tear evaporation. Miebo, a perfluorohexyloctane ophthalmic solution, focuses on alleviating signs and symptoms of dry eye, particularly in cases of evaporative dry eye. Notably, Miebo is a single-ingredient eye drop that is free from water, preservatives, and steroids, providing quick and comfortable spread to reduce tear evaporation at the ocular surface.
In February 2025, Abdi İbrahim İlaç Sanayi ve Ticaret A.Ş., a Turkey-based pharmaceutical company, partnered with Rohto Pharmaceutical to launch innovative eye care products in Turkey. The collaboration aims to introduce advanced eye care technologies, including TearShield-based formulations, improve patient experience, and strengthen both companies’ presence in the ophthalmic market. Rohto Pharmaceutical Co., Ltd., based in Japan, specializes in pharmaceuticals, cosmetics, and other fast-moving consumer goods.
Major companies operating in the dry eye products market are Alcon Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., URSAPHARM Arzneimittel GmbH, AFT Pharmaceuticals Limited, Novaliq GmbH, Théa Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Lupin Limited, Pfizer Inc., Merck & Co. Inc., Bayer AG, Prestige Consumer Healthcare Inc., Similasan AG.
North America was the largest region in the dry eye products market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dry eye products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dry eye products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the dry eye products market by increasing costs of imported pharmaceutical ingredients, packaging materials, applicators, and formulation equipment. Manufacturers and distributors in North America and Europe are most affected due to dependence on global supply chains, while Asia-Pacific faces pricing pressure on finished product exports. These tariffs are contributing to higher retail prices and margin pressures. However, they are also encouraging local formulation, regional manufacturing expansion, and diversification of ingredient sourcing strategies.
The dry eye products market research report is one of a series of new reports that provides dry eye products market statistics, including dry eye products industry global market size, regional shares, competitors with a dry eye products market share, detailed dry eye products market segments, market trends and opportunities, and any further data you may need to thrive in the dry eye products industry. This dry eye products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Dry eye products are designed to address and alleviate the symptoms of dry eye syndrome, a condition characterized by insufficient tear production or rapid evaporation of tears. These products work by lubricating the eyes, reducing inflammation, and increasing moisture to provide relief from dryness, irritation, and discomfort.
The primary categories of dry eye products include antibiotic drops, hormone drops, artificial tears, and other formulations. Antibiotic drops, specifically designed for ophthalmic (eye) use, incorporate antibiotics to eliminate infections and mitigate inflammation, ultimately easing the symptoms associated with dry eye disease. These products encompass both prescription and over-the-counter drugs, available through various distribution channels such as hospital pharmacies, retail pharmacies, specialty clinics, e-commerce, and other outlets.
The dry eye products market consists of sales of cyclosporine, corticosteroids, and lifitegrast. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Dry Eye Products Market Characteristics
3. Dry Eye Products Market Supply Chain Analysis
4. Global Dry Eye Products Market Trends and Strategies
5. Dry Eye Products Market Analysis of End Use Industries
7. Global Dry Eye Products Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Dry Eye Products Total Addressable Market (TAM) Analysis for the Market
9. Dry Eye Products Market Segmentation
10. Dry Eye Products Market Regional and Country Analysis
11. Asia-Pacific Dry Eye Products Market
12. China Dry Eye Products Market
13. India Dry Eye Products Market
14. Japan Dry Eye Products Market
15. Australia Dry Eye Products Market
16. Indonesia Dry Eye Products Market
17. South Korea Dry Eye Products Market
18. Taiwan Dry Eye Products Market
19. South East Asia Dry Eye Products Market
20. Western Europe Dry Eye Products Market
21. UK Dry Eye Products Market
22. Germany Dry Eye Products Market
23. France Dry Eye Products Market
24. Italy Dry Eye Products Market
25. Spain Dry Eye Products Market
26. Eastern Europe Dry Eye Products Market
27. Russia Dry Eye Products Market
28. North America Dry Eye Products Market
29. USA Dry Eye Products Market
30. Canada Dry Eye Products Market
31. South America Dry Eye Products Market
32. Brazil Dry Eye Products Market
33. Middle East Dry Eye Products Market
34. Africa Dry Eye Products Market
36. Dry Eye Products Market Competitive Landscape and Company Profiles
37. Dry Eye Products Market Other Major and Innovative Companies
40. Dry Eye Products Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Dry Eye Products Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses dry eye products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for dry eye products? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dry eye products market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Artificial Tears; Anti-Inflammatory Eye Drops; Lubricating Ointments And Gels; Tear Conservation Products; Other Product Types2) By Formulation: Preservative-Free Formulations; Preserved Formulations; Gel-Based Formulations; Ointment-Based Formulations
3) By Drug Category: Prescription Dry Eye Therapies; Over-The-Counter Dry Eye Products
4) By Disease Severity: Mild Dry Eye; Moderate Dry Eye; Severe Dry Eye
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies And E-Commerce; Ophthalmology And Specialty Clinics
Subsegments:
1) By Artificial Tears: Preservative-Free Artificial Tears; Preserved Artificial Tears; Lipid-Based Artificial Tears; Electrolyte-Balanced Artificial Tears2) By Anti-Inflammatory Eye Drops: Cyclosporine-Based Eye Drops; Lifitegrast-Based Eye Drops; Corticosteroid Eye Drops (Short-Term Use)
3) By Lubricating Ointments And Gels: Night-Time Lubricating Ointments; Gel-Based Lubricants; Petrolatum-Based Ointments
4) By Tear Conservation Products: Punctal Plugs; Tear-Retaining Inserts; Moisture Chamber Eye Shields
5) By Other Product Types: Rewetting Drops For Contact Lens Users; Dry Eye Relief Sprays; Lid-Margin Cleansing Solutions
Companies Mentioned: Alcon Inc.; Johnson & Johnson; AbbVie Inc.; Novartis AG; Bausch Health Companies Inc.; Santen Pharmaceutical Co. Ltd.; Rohto Pharmaceutical Co. Ltd.; Otsuka Pharmaceutical Co. Ltd.; URSAPHARM Arzneimittel GmbH; AFT Pharmaceuticals Limited; Novaliq GmbH; Théa Pharmaceuticals; Sun Pharmaceutical Industries Ltd.; Cipla Ltd.; Lupin Limited; Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Prestige Consumer Healthcare Inc.; Similasan AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Dry Eye Products market report include:- Alcon Inc.
- Johnson & Johnson
- AbbVie Inc.
- Novartis AG
- Bausch Health Companies Inc.
- Santen Pharmaceutical Co. Ltd.
- Rohto Pharmaceutical Co. Ltd.
- Otsuka Pharmaceutical Co. Ltd.
- URSAPHARM Arzneimittel GmbH
- AFT Pharmaceuticals Limited
- Novaliq GmbH
- Théa Pharmaceuticals
- Sun Pharmaceutical Industries Ltd.
- Cipla Ltd.
- Lupin Limited
- Pfizer Inc.
- Merck & Co. Inc.
- Bayer AG
- Prestige Consumer Healthcare Inc.
- Similasan AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 8.62 Billion |
| Forecasted Market Value ( USD | $ 11.13 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
